Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Neoplasia (New York, N.Y.)|October 5, 2011
NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancerTatsuhiro Shibata, Akiko Kokubu, Shigeru Saito, et al.Journal of the American Medical Directors Association|November 16, 2025
Five-Year Functional and Cognitive Trajectories Following Cardiac Surgery in Older Adults: A Prospective StudyPatrick F M Corbett, Asma Sadoun, Yuki Yoshimatsu, et al.Cells|October 23, 2021
The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision MedicineAoi Komatsu, Kotaro Matsumoto, Yuki Yoshimatsu, et al.Journal of Personalized Medicine|November 27, 2021
Establishment and Characterization of NCC-DDLPS4-C1: A Novel Patient-Derived Cell Line of Dedifferentiated LiposarcomaRyuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, et al.Human Cell|March 7, 2021
Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcomaRyuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, et al.Human Cell|August 10, 2022
Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcomaYuki Yoshimatsu, Rei Noguchi, Yooksil Sin, et al.Human Cell|August 4, 2022
Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumorTaro Akiyama, Yuki Yoshimatsu, Rei Noguchi, et al.Human Cell|April 20, 2022
Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, et al.Human Cell|September 14, 2022
Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapyTaro Akiyama, Yuki Yoshimatsu, Rei Noguchi, et al.Human Cell|July 25, 2021
Establishment and characterization of novel patient-derived cell lines from giant cell tumor of boneYuki Yoshimatsu, Rei Noguchi, Ryuto Tsuchiya, et al.Pageof 12